Mucofortin (Acetylcysteine)

Acetylcysteine works by breaking disulfide bonds in mucus glycoproteins, which reduces the viscosity and elasticity of sputum. This chemical action makes the mucus less sticky, allowing ciliary movement and coughing to more effectively clear the airways.

The appropriate dose of Mucofortin is determined by the prescribing healthcare professional based on the patient’s age, condition severity, and renal function. Patients should follow the exact regimen provided by their clinician and not adjust the dose on their own.

Safety data for acetylcysteine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Mucofortin.

To order Mucofortin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mucofortin’s active ingredient, acetylcysteine, directly cleaves disulfide bonds in mucus, offering a rapid reduction in viscosity. Compared with agents such as carbocisteine, which modify mucus production, acetylcysteine provides a more immediate thinning effect, making it useful for acute exacerbations.

Mucofortin should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Mucofortin is taken orally as directed by a healthcare professional. It may be swallowed whole with water or, if formulated as a liquid, measured with a calibrated device. The exact method of administration should follow the prescriber’s instructions.

The most serious risks include severe allergic reactions such as anaphylaxis, angioedema, and bronchospasm. Patients should seek immediate medical attention if they experience difficulty breathing, swelling of the face or throat, or any signs of a severe hypersensitivity reaction.

Mucofortin should be avoided in individuals with a known hypersensitivity to acetylcysteine or any of its excipients. Patients with severe renal impairment should use it only under medical supervision, and those with uncontrolled asthma should be monitored closely for bronchospasm.